{"id":"W4379283976","doi":"10.1200/jco.2023.41.16_suppl.4502","title":"Final prespecified overall survival (OS) analysis of CLEAR: 4-year follow-up of lenvatinib plus pembrolizumab (L+P) vs sunitinib (S) in patients (pts) with advanced renal cell carcinoma (aRCC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Renal cell carcinoma; Urology; Sunitinib; Gastroenterology; Confidence interval; Everolimus; Hazard ratio; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052897,0.0008720729,0.001667684,0.0005178842,0.0003779367,0.0009754067,0.0007508168,0.0009397043,0.00231929],"category_scores_gemma":[0.00274226,0.0003381581,0.003354628,0.0004064315,0.0004056974,0.0008855707,0.0007307878,0.001438837,0.0004036554],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008889269,"about_ca_system_score_gemma":0.001039852,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000665479,"about_ca_topic_score_gemma":0.001981003,"domain_scores_codex":[0.9982421,0.0009094746,0.0001211474,0.0003007274,0.0002300317,0.0001964395],"domain_scores_gemma":[0.9974693,0.0007099556,0.0007981111,0.0003109886,0.0002488768,0.0004628417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8278146,0.005866138,0.07756177,0.0008617621,0.01129263,0.000259122,0.0002389082,0.007182779,0.01729365,0.0002043295,0.00378193,0.04764241],"study_design_scores_gemma":[0.1069715,0.330137,0.5224193,0.0001124681,0.0159391,0.0005813788,0.0001771304,0.005568923,0.01027534,0.0005516037,0.007151996,0.0001141349],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892592,0.001397698,0.0009034185,0.0001444906,0.00003895229,0.0009069272,0.005871378,0.00004470048,0.001433348],"genre_scores_gemma":[0.9850326,0.0002584426,0.000964087,0.000257634,0.00005797293,0.0007374664,0.01148514,0.00002032477,0.001186424],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0052897,"threshold_uncertainty_score":0.02797496,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1152976816713396,"score_gpt":0.3854609462312064,"score_spread":0.2701632645598668,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}